ATE349444T1 - 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff - Google Patents

5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff

Info

Publication number
ATE349444T1
ATE349444T1 AT02779711T AT02779711T ATE349444T1 AT E349444 T1 ATE349444 T1 AT E349444T1 AT 02779711 T AT02779711 T AT 02779711T AT 02779711 T AT02779711 T AT 02779711T AT E349444 T1 ATE349444 T1 AT E349444T1
Authority
AT
Austria
Prior art keywords
thiazolidine
pyridyl
ethoxy
benzyl
amino
Prior art date
Application number
AT02779711T
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127934A external-priority patent/GB0127934D0/en
Priority claimed from GB0127936A external-priority patent/GB0127936D0/en
Priority claimed from GB0127935A external-priority patent/GB0127935D0/en
Priority claimed from GB0127937A external-priority patent/GB0127937D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE349444T1 publication Critical patent/ATE349444T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
AT02779711T 2001-11-21 2002-11-21 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff ATE349444T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0127934A GB0127934D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127936A GB0127936D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127935A GB0127935D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127937A GB0127937D0 (en) 2001-11-21 2001-11-21 Novel compounds

Publications (1)

Publication Number Publication Date
ATE349444T1 true ATE349444T1 (de) 2007-01-15

Family

ID=27448006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02779711T ATE349444T1 (de) 2001-11-21 2002-11-21 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff

Country Status (14)

Country Link
EP (1) EP1448559B1 (de)
JP (1) JP2005513038A (de)
KR (1) KR20040062963A (de)
CN (1) CN100390170C (de)
AT (1) ATE349444T1 (de)
AU (1) AU2002343050A1 (de)
CY (1) CY1106397T1 (de)
DE (1) DE60217168T2 (de)
DK (1) DK1448559T3 (de)
ES (1) ES2278977T3 (de)
HK (1) HK1068884A1 (de)
PT (1) PT1448559E (de)
SI (1) SI1448559T1 (de)
WO (1) WO2003045946A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
WO2002051839A1 (en) * 2000-12-22 2002-07-04 Smithkline Beecham P.L.C. 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt

Also Published As

Publication number Publication date
ES2278977T3 (es) 2007-08-16
CN100390170C (zh) 2008-05-28
KR20040062963A (ko) 2004-07-09
PT1448559E (pt) 2007-03-30
CN1612875A (zh) 2005-05-04
EP1448559A1 (de) 2004-08-25
DK1448559T3 (da) 2007-04-30
EP1448559B1 (de) 2006-12-27
JP2005513038A (ja) 2005-05-12
DE60217168T2 (de) 2007-10-04
HK1068884A1 (en) 2005-05-06
CY1106397T1 (el) 2011-10-12
WO2003045946A1 (en) 2003-06-05
AU2002343050A1 (en) 2003-06-10
DE60217168D1 (de) 2007-02-08
SI1448559T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
EA200200975A1 (ru) Гидрохлорид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси] бензил]тиазолидин-2,4-диона
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
ATE349444T1 (de) 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
EA200101102A1 (ru) Новый фармацевтический препарат
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
EA200300230A1 (ru) Тартратная соль производного тиазолидиндиона
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
EA200300231A1 (ru) Тартратные соли производного тиазолидиндиона
EA200300232A1 (ru) Тартратные соли производного тиазолидиндиона
EA200300423A1 (ru) Производное тиазолидиндиона и его применение в качестве противодиабетического лекарственного средства

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1448559

Country of ref document: EP

REN Ceased due to non-payment of the annual fee